Antibacterial properties of whole body extracts and haemolymph of Lucilia sericata maggots
- PMID: 17385589
- DOI: 10.12968/jowc.2007.16.3.27011
Antibacterial properties of whole body extracts and haemolymph of Lucilia sericata maggots
Abstract
Objective: To partially characterise maggot-secreted antibacterial substances and determine their range of activity against different bacteria.
Method: Sterile and non-sterile maggots maintained in the laboratory and taken from chronic wounds of treated patients were used. Whole body extracts and haemolymph were fractionated and their range of activity against bacteria was tested using the zone of inhibition assay. The mode of action of bacterial destruction was examined by viable counts, influx of K+ and changes in the membrane potential by scanning electron microscope (SEM).
Results: Extracts of sterile and non-sterile maggots showed an activity of 200 arbitrary units (AU)/ml and 400AU/ml respectively. Maggots removed from chronic wounds had an activity of 1200AU/ml. Injuring sterile maggots with a sterile needle doubled the antibacterial activity within 24 hours, while the antibacterial activity of haemolymph increased fourfold after injury with a sterile needle and sixteenfold with an infected needle. The fractions with a molecular weight of < 1kDa and 3-10kDa showed antibacterial activity against Gram-positive and Gram-negative bacteria including Pseudomonas aeruginosa, Klebsiella pneumoniae and methicillin-resistant Staphylococcus aureus (MRSA) isolated from wounds. The fraction with a molecular weight of < 1kDa lysed over 90% of the bacteria within 15 minutes by causing an influx of K+ and changing the membrane potential of bacteria.
Conclusion: The nature of the antibacterial materials extracted from maggots not only indicates their ability to ingest the necrotic tissue on the wound, but also their potential significance in wound healing,
Similar articles
-
The antibacterial activity against MRSA strains and other bacteria of a <500Da fraction from maggot excretions/secretions of Lucilia sericata (Diptera: Calliphoridae).Microbes Infect. 2008 Apr;10(4):325-33. doi: 10.1016/j.micinf.2007.12.011. Epub 2007 Dec 28. Microbes Infect. 2008. PMID: 18400544
-
In vitro antibacterial effects of Cinnamomum extracts on common bacteria found in wound infections with emphasis on methicillin-resistant Staphylococcus aureus.J Ethnopharmacol. 2014 May 14;153(3):587-95. doi: 10.1016/j.jep.2014.02.044. Epub 2014 Mar 5. J Ethnopharmacol. 2014. PMID: 24613273
-
Antibacterial substances of low molecular weight isolated from the blowfly, Lucilia sericata.Med Vet Entomol. 2007 Jun;21(2):127-31. doi: 10.1111/j.1365-2915.2007.00668.x. Med Vet Entomol. 2007. PMID: 17550431
-
[Maggot therapy in wound management].Tidsskr Nor Laegeforen. 2009 Sep 24;129(18):1864-7. doi: 10.4045/tidsskr.08.0656. Tidsskr Nor Laegeforen. 2009. PMID: 19844278 Review. Norwegian.
-
[Biosurgical débridement using Lucilia sericata-maggots - an update].Wien Med Wochenschr. 2010 Dec;160(21-22):578-85. doi: 10.1007/s10354-010-0806-1. Epub 2010 Aug 16. Wien Med Wochenschr. 2010. PMID: 20714816 Review. German.
Cited by
-
Maggots as potential vector for pathogen transmission and consequences for infection control in waste management.GMS Hyg Infect Control. 2015 May 6;10:Doc07. doi: 10.3205/dgkh000250. eCollection 2015. GMS Hyg Infect Control. 2015. PMID: 26029492 Free PMC article.
-
Selection and Evaluation of Tissue Specific Reference Genes in Lucilia sericata during an Immune Challenge.PLoS One. 2015 Aug 7;10(8):e0135093. doi: 10.1371/journal.pone.0135093. eCollection 2015. PLoS One. 2015. PMID: 26252388 Free PMC article.
-
Proline-Rich Antimicrobial Peptides in Medicinal Maggots of Lucilia sericata Interact With Bacterial DnaK But Do Not Inhibit Protein Synthesis.Front Pharmacol. 2020 Apr 24;11:532. doi: 10.3389/fphar.2020.00532. eCollection 2020. Front Pharmacol. 2020. PMID: 32390853 Free PMC article.
-
A zone-of-inhibition assay to screen for humoral antimicrobial activity in mosquito hemolymph.Front Cell Infect Microbiol. 2023 Jan 26;13:891577. doi: 10.3389/fcimb.2023.891577. eCollection 2023. Front Cell Infect Microbiol. 2023. PMID: 36779191 Free PMC article.
-
Larval therapy for leg ulcers (VenUS II): randomised controlled trial.BMJ. 2009 Mar 19;338:b773. doi: 10.1136/bmj.b773. BMJ. 2009. PMID: 19304577 Free PMC article. Clinical Trial.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical